Brief: Tang Capital Management Reports 5.1% Stake In Aurinia Pharmaceuticals Inc As Of September 6 - SEC Filing
12/09/2024 22:54
Aurinia Pharmaceuticals Inc AUPH.O :
* TANG CAPITAL MANAGEMENT REPORTS 5.1% STAKE IN AURINIA
PHARMACEUTICALS INC AS OF SEPTEMBER 6 - SEC FILING
Source text for Eikon: ID:n0001214659-24-016381
Further company coverage: AUPH.O
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death